SGX Listed Stock

HAW PAR CORP LTD (SGX:H02)


HAW PAR CORP LTD (SGX:H02) @ SGinvestors.io
SGD 11.050
-0.130 / -1.16%
Share Price as of: 2022-06-28 16:48
Market / ISIN Code: SGX Mainboard / SG1D25001158
Sector / Industry Group / Industry: Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals


Haw Par Blogger ArticlesHAW PAR CORP LTD Blogger Articles SGX Listed Haw Par (SGX:H02) Blogger Articles H02.SI Blogger Articles
Phillip CFD
Vanessa Wong
2022-05-04 16:40:33
Celebrating World Health Day – Shining the Spotlight on 2 Healthcare Related Stocks
Celebrating World Health Day – Shining the Spotlight on 2 Healthcare Related Stocks Facebook0Pinterest0TwitterLinkedinReddit0 Jeremy Chua, Dealing  Jeremy graduated from Nanyang Technological University with a Bachelor’s Degree in Business and is a member of the largest dealing team in Phillip Securities. He strongly believes in the importance of staying invested in the financial markets and evaluates stocks using fundamentals to make informed investment decisions. In his free time, he enjoys researching on market events and disruptive investment themes to generate new investment ideas for the short and long term. Chua Minghan, Assistant Manager, Dealing Chua Minghan graduated from the National University of Singapore with a Bachelor’s d
Scg8866t Stockinvesting
SCG8866T
2021-04-01 15:45:23
Portfolio Review for March 2021
  Please click and read this disclaimer if you wish to continue with the contents below. For my previous portfolio review click here YTD(2021) I have made a total profit of S$40,366.60 from my equity investments(predominantly in HK) with an XIRR of 85.56%(XIRR is annualized). From my 6 years of tracking, I have made a total of S$140,009.26 from this portfolio alone. In terms of benchmarking with STI, HKSE and World index. There was a substantial pullback recently due to inflation and interest rate worries. The large difference between my XIRR and TWR is due to XIRR being annualized in nature and the price appreciation of some of my stocks recently. Portfolio composition(4 index etfs and 26 stocks): Transactions: Sold all Haw Par(SG:H
Scg8866t Stockinvesting
SCG8866T
2021-02-11 23:54:08
Portfolio Review for CNY 2021
  Please click and read this disclaimer if you wish to continue with the contents below. For my previous portfolio review click here YTD(2021) I have made a total profit of S$100,926.24 from my equity investments(predominantly in HK) with an XIRR of 2,562.89%(XIRR is annualized). From my 6 years of tracking, I have made a total of S$200,568.90 from this portfolio alone. In terms of benchmarking with STI, HKSE and World index, I seem to have made further improvements in 2021. I have started to outperform the World index. The large difference between my XIRR and TWR is due to XIRR being annualized in nature and the drastic price appreciation of some of my stocks recently. Portfolio composition(4 index etfs and 25 stocks): Transactions:Initiated a position





Investment BloggerSG Investment BlogSG Invest BloggersBloggers Say








Your Say











Stock / REIT Search

Advertisement

Advertisement